TNFRSF13B/TACI Mutations in Patients with Chronic Rhinosinusitis with Nasal Polyps

Am J Rhinol Allergy. 2023 Jan;37(1):74-77. doi: 10.1177/19458924221134731. Epub 2022 Oct 27.

Abstract

Background: The pathogenesis of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) remains still inconclusive. Recent studies identified an increased expression of BAFF (a B cell-activating factor) and its receptor TACI (Transmembrane Activator and cAML Interactor) in nasal polyp samples, while TNFRSF13B/TACI mutations have been found in patients with benign lymphoproliferative disorders and primary antibody deficiencies.

Objective: The aim of our study was to evaluate the possible contribution of TNFRSF13B/TACI mutations in CRSwNP pathogenesis.

Methods: Forty-four (44) patients with CRSwNP (male/female: 33/11, mean age: 52.5 years, range: 16-83) were analyzed for TNFRSF13B/TACI mutations by PCR-sequencing.

Results: No pathogenic TNFRSF13B/TACI mutations were identified in our cohort study of CRSwNP patients. We detected two common missense mutations (p.P251L and p.V220A), along with other common silent mutations and intronic polymorphisms in an identical prevalence to healthy control population.

Conclusion: TNFRSF13B/TACI mutations might not play a role in the pathogenesis of CRSwNP.

Keywords: CRS; CRSwNP; Chronic Rhinosinusitis with Nasal Polyps; TACI mutations; TNFRSF13B; chronic Rhinosinusitis; nasal polyps; p.P251L; p.V220A; sinusitis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Chronic Disease
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Nasal Polyps* / genetics
  • Rhinitis* / genetics
  • Sinusitis* / genetics
  • Transmembrane Activator and CAML Interactor Protein* / genetics
  • Young Adult

Substances

  • TNFRSF13B protein, human
  • Transmembrane Activator and CAML Interactor Protein